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Advanced resuscitation techniques are dependent on drug 
therapy to increase survival. Because drugs must reach 
their site of action instantaneously, the choice of appro•
priate route of administration may be critical. To study 
the pharmacokinetics of drug administration by periph•
eral and central venous routes during resuscitation, nine 
mongrel dogs were studied. Arterial blood pressure and 
electrocardiograms were monitored continuously. Car•
diac output was evaluated before resuscitation to deter•
mine control levels. After thoracotomy and fibrillation 
of the heart, cardiac massage was started with a fre•
quency of compression maintained at 60/min. 
Bolus injections of two different radioisotopes were 
given simultaneously through a peripheral and a central 
vein. Isotope activity was sampled through a catheter in 
the right femoral artery at 5 second intervals for 90 
seconds and at 30 second intervals for 210 seconds. The 
Advanced resuscitation techniques are usually dependent on 
drug therapy to achieve success and reduce morbidity. Be•
cause drugs must reach their site of action rapidly at a time 
of impaired circulation, the choice of an appropriate route 
of administration may be critical. There are few and con•
troversial data (1-4) regarding the choice of the most ef•
ficacious route during advanced resuscitation efforts. 
During advanced resuscitative efforts, drugs may be ad•
ministered through the endotracheal or intravenous route 
(5). The intravenous route may be peripheral or central. If 
there is a significant difference between drug transit times 
from different intravenous sites to the central circulation, 
the choice of the intravenous site during resuscitation could 
be a crucial management decision. Although the pharma-
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major differences between the two routes of adminis•
tration were that central injection produced a 270% 
higher peak concentration (p < 0.001) and significantly 
shorter lag times to the first appearance of tracer (16 ± 
7 versus 38 ± 13 seconds, p < 0.05) and times to peak 
concentration (13 ± 5 versus 27 ± 12 seconds, p < 
0.01). In contrast, there were no significant differences 
in area under the time-counts curve, mean residence 
time, total body clearance and steady state volume of 
distribution. The central compartment volume of dis•
tribution was significantly smaller after central than after 
peripheral injection (26.1 ± 56 versus 76.3 ± 16.5 ml, 
p < 0.01). The therapeutic implications of these findings 
must be investigated for individual drugs used during 
cardiorespiratory resuscitation to determine the most 
appropriate route and dosage for each agent. 
(J Am Coil CardioI1985;6:1073-7) 
cokinetics of drug administration by the peripheral venous 
route are well established, data are lacking (5) concerning 
the kinetics of drug administration directly into the central 
circulation, especially during resuscitation. To the best of 
our knowledge, no studies have compared both routes of 
drug administration during resuscitation in the same prep•
aration under controlled conditions. Therefore, this study 
was conducted to determine the pharmacokinetics of drug 
administration by peripheral and central venous routes dur•
ing well controlled cardiopulmonary resuscitation in open 
chest dogs. 
Methods 
Animal preparation. Nine mongrel dogs weighing 9 to 
15 kg were included in this study. After the dogs were 
anesthetized with phenobarbital sodium (30 mg/kg body 
weight intravenously) and intubated with a cuffed endotra•
cheal tube, catheters were placed in the right femoral artery, 
for recording of blood pressure, in the left femoral artery 
for withdrawal of blood samples and in the right brachial 
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vein and superior vena cava for injection of tracers. An 
electromagnetic flow probe was placed around the ascending 
aorta just above its root, and instantaneous aortic blood flow 
was recorded by a square wave electromagnetic flow meter 
(model 501, Carolina Medical Electronics). The frequency 
response of the flow meter was selected at 30 Hz with a 
time lag of less than 3 ms. The velocity curve recorded by 
the probe was a true reflection of actual flow, because the 
circumference of the aorta was constant and the probe fit 
tightly around the aorta. The arterial pressure and electro•
cardiogram were monitored continuously and recorded on 
a multichannel recorder. 
Induction of fibrillation and cardiopulmonary resus•
citation. Ventricular fibrillation was produced by a 100 W-s 
direct-current shock. After 30 seconds, cardiac massage was 
started with a frequency of compression maintained at 6O/min. 
One person performed compression for the duration of the 
experiment in each dog, to keep an even cardiac output. 
Figure 1. Simulated (A) and observed (B) arterial blood concen•
tration of the tracer after central venous administration (data pro•
jected as mean ± SEM). CPM = counts per minute. 
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Drug administration. After blood pressure during re•
suscitation had stabilized (25 to 30 seconds), a bolus injec•
tion of 2 ml of iodine-125 (50 X 106 counts/min) was 
injected into the right brachial vein; simultaneously, a bolus 
injection of 2 ml of chromium-51 (50 X 106 counts/min) 
was injected into the superior vena cava. Both isotopes were 
compounds of sodium, Na l31 I and Na251Cr04 (Amersham) 
and both injections lasted approximately 3 seconds. 
Blood samples were obtained through the catheter in the 
right femoral artery at 5 second intervals for 90 seconds 
after the bolus injections and at 30 second intervals for an 
additional 210 seconds after injection. Activity in each sam•
ple was counted in a well scintillation counter. 
Data analysis. Time intervals to the first appearance of 
tracer at the sampling site (lag time) and from that point to 
the peak counts per minute value (time to peak) were de•
termined directly from the plasma counts per minute versus 
time curves. Pharmacokinetic analysis of these curves was 
performed in two ways: I) The data were fitted to a two 
compartment open-body model assuming a constant rate 
infusion input (subsequent to the lag time) of duration equal•
ing time to peak, and a constant rate of elimination from 
the central compartment (6). Fitting was implemented on 
an HP-85 microcomputer using an iterative nonlinear regres•
sion program (7) and yielded estimates of the central com•
partment volume of distribution and intercompartmental rate 
constants. 2) Model-independent noncompartmental deter•
minations (8,9) were made of the steady state volume of 
distribution, total body clearance and mean residence time 
of the tracer, as well as the area under the time-counts curve. 
Times, volume and clearance values for the two routes 
of administration were compared by paired t tests. Data are 
presented as mean ± SD. 
Results 
Hemodynamics. Control cardiac output averaged 
3.7 ± 1.4 liters/min. The cardiac output during resuscitation 
was 0.67 ± 0.07 liters/min (range 0.6 to 0.7) or 18% of 
control cardiac output. The systolic blood pressure averaged 
85 ± 17 mm Hg before induction of ventricular fibrillation 
and 32 ± 10 mm Hg during resuscitation. None of the nine 
dogs regained a spontaneous electrocardiographic complex 
or pulsatile blood pressure during the experiment. Data from 
the peripheral injection in Dog 1 were not included in the 
pharmacokinetic analyses because of difficulty during the 
injection. 
Pharmacokinetics. The central and the peripheral ve-
nous injections produced concentration-time curves that dif-
fered during the first 100 seconds (Fig. I and 2). Central 
injection produced a significantly higher peak concentration 
(620 ± 21 X 103 versus 226 ± 84 x 103 counts/min, 
p < 0.001) and significantly shorter lag time (16 ± 7 versus 
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Figure 2. Simulated (A) and observed (B) arterial blood concen•
tration of the tracer after peripheral venous administration (data 
projected as mean ± SEM). CPM = counts per minute. 
38 ± 13 seconds, p < 0.05) and time to peak (13 ± 5 
versus 27 ± 12 seconds, p < 0.01). In contrast, values for 
area under the time-counts curve, mean residence time, total 
body clearance and steady state volume of distribution (VDs,) 
did not differ significantly with the two routes of admin•
istration (Table 1). The central compartment volume of dis•
tribution (V c) was significantly smaller after central injection 
(26.1 ± 5.6 versus 76.3 ± 16.5 ml, p < 0.01) with a 
proportionately elevated VDsJVc ratio (4.4 ± 2.0 versus 
1.60 ± 0.33, p < 0.01). 
The mean residence time for tracers was 64.6 ± 20.5 
seconds in the systemic circulation (56.5 ± 18.1 seconds 
for the central injection and 74.6 ± 21 seconds for the 
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peripheral injection, p = NS); clearance for both injection 
routes occurred at a rate of 154 ± 41 ml/min. Given the 
total blood flow rate of 0.68 ± 0.75 liters/min during the 
experiment, this clearance value represents 22.6% of total 
blood flow. 
Discussion 
The criteria now used for drug administration during 
resuscitation have evolved empirically and are not based on 
sound scientific data (2,5,6,10). The findings of our study 
indicate that the central venous and peripheral venous routes 
of drug administration durirtg cardiopulmonary resuscitation 
result in pharmacokinetic differences. 
Central versus peripheral venous injection. The most 
prominent difference between the central venous and the 
peripheral venous injections was the difference between the 
peak levels of tracer. The tracer enters the circulation on 
the venous side in both injections; the difference in peak 
levels can be attributed to the greater amount of tracer mix•
ing that takes place after peripheral venous injection than 
after central venous injection. After central venouS injec•
tion, the tracer mixes only with the blood present in the 
vena cava, the right side of the heart and the pulmonary 
artery circulation before reaching the sampling site. After 
peripheral venous injection, the tracer mixes with blood in 
the superior vena cava coming from the head and foreleg. 
Therefore, the peripheral injected bolus is considerably more 
dilute when it reaches the level of the sampling point and 
the tracer concentration is correspondingly lower. In choos•
ing the kinetic model employed, we assigned our lag-time 
value to this venous-pulmonary sequestration phase, which 
clamped the initial bolus injection and converted it into a 
brief constant rate infusion, as seen by the arterial sampling 
site. The time to peak value estimates the duration of this 
Table 1. Kinetic Variables After Central Venous and Peripheral Venous Injection of Tracers 
During Cardiopulmonary Resuscitation in Dogs 
Lag time (seconds) 
Time to peak (seconds) 
Peak tracer concentration 
(counts/min per ml) 
Area under the curve 
(counts/min x 103 x min x ml I) 
Mean residence time (seconds) 
Clearance (ml/min) 
Estimated steady state 
volume of distribution (m!) 
Estimated volume 
of distribution, central 
compartment (ml) 
Volume ratio (VD"lVc ) 
Central Injection 
16 ± 7 
13 ± 5 
620 ± 21 x 103 
356 ± 90 
56.5 ± 18.1 
133 ± 22 
132 ± 26 
26.1 ± 5.6 
4.4 ± 2.0 
Peripheral Injection 
38 ± 13+ 
27 ± 12t 
226 ± 84 x 103 • 
338 ± 126 
74.6 ± 21 
162 ± 49 
192 ± 44 
76.3 ± 16.5t 
1.60 ± 0.33t 
'p < 0.001; tp < 0.01; +p < 0.05. Vc = estimated volume of distribution, central compartment; VD" = 
estimated steady state volume of distribution. 
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rapid infusion. These points underlie the differences found 
between the two injection routes (Fig. 3). 
The peripheral injection results in a longer lag time and 
time to peak as well as a larger central compartment volume 
of distribution as a result of the additional venous blood 
admixture for the peripheral venous injection route. This 
venous mixing also explains the considerable difference in 
peak concentration produced by the two injection routes. 
Nevertheless, the similar values produced by the two routes 
for the area under the time-counts curve, mean residence 
time and steady state volume of distribution emphasize the 
overall similarity of drug dose and disposition for both routes 
of administration. 
Comparison with previous studies. In studies (4) on 
two different groups of dogs during open chest resuscitation, 
peak lidocaine levels were higher after the central than after 
the peripheral venous injection, but contrary to our results, 
no significant qifferences were found in times to effective 
and peak lidocaine concentration. However, no direct com•
parisons in the same dog were made in that study, and 
because of sampling at 20 second interval, the peak levels 
might be missed. Our experimental design enabled us to 
make direct comparisons and to generate a blood concen•
tration-time CJlrv~ of high temporal resolution, which is of 
significant importance in analyzing pharmacokinetics of a 
drug during the n;latively short period of cardiopulmonary 
resuscitation. 
A study by Kuhn et al. (3) performed during closed chest 
resuscitation in two groups of three patients showed a peak 
level of dye in femoral artery samples at 30 seconds after 
Figure 3. Simul'lted arterial blood concentration of the tr'lcers 
after central and peripheral Venous administration. Boxes show 
the pharmacokinetic model employed for data analysis. I = central 
compartment; 2 = peripheral compartment; CPM = counts per 
minute. 
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central venous injection. However, after peripheral venous 
injection, no peak was established in the 5 minute study 
period. Cardiac output was not measured in that study and 
because cardiac output during closed chest resuscitation may 
vary widely (II), this might be a significant limitation in 
interpreting results in such a small number of patients. Our 
experimental design enabled us to make a direct comparison 
between the central and peripheral routes under constant 
hemodynamic conditions. However, the discrepancies be•
tween our study and that of Kuhn et al. may be attributable 
to differences in blood flow patterns between open chest 
canine resuscitation and closed chest human resuscitation. 
Methodologic considerations. It has been shown (II) 
that cardiac output during closed chest resuscitation in hu•
mans probably varies between 5 and 30% of normal. 8e•
~ause one of our objectives was to establish an experimental 
design giving a constant cardiac output during resuscitation, 
we chose the oPen chest method. We adjusted our rate of 
compression to consistently produce a cardiac output of 18% 
of the value before induction of ventricular fibrillation. 
Although the characteristics of blood flow may differ 
slightly between open and closed chest resuscitation, we 
believe that our experimental design is valid for studying 
pharmacokinetics of drugs during markedly decreased car•
diac output. Studies by Voorhees et al. (12) raised the ques•
tion about the relation between arterial ~ow above and below 
the diaphragm during resuscitation. This question is relevant 
to our data because our sampling site was the femoral artery. 
However, recent data of Bellamy et al. (13) demonstrated 
comparable radiomicrosphere mixing in the ascending and 
abdominal aorta during cardiopulmonary resuscitation in 
pigs, sl!ggesting that femoral sampling is adequate for phar•
macokinetic evaluation. Moreover, our own data indicate 
that adequate flow was maintained below the diaphragm 
during our experimental procedure. This is demonstrated by 
the tracer clearance value of 154 mllmin, which is equal to 
23% of cardiac output obtained. In view of the prevailing 
of renal and hepatic blood flow during resuscitation, the 
clearance mechanism is highly dependent onland approxi•
mates blood flow (15). The value obtained indicates that 
nearly a quarter of the cardiac output was reaching the 
peripheral arterial circulation. 
Clinical implications. Because the kinetics of tracers 
do not necessarily represent the kinetics of drug molecules, 
whose distribution and elimination characteristics may be 
quite different, immediate therapeutic implications must be 
interpreted with caution. 
The most significant finding of our study is that central 
and peripheral venous administration routes result in definite 
differences in peak tracer concentration, lag time and time 
to peak concentration during cardiorespiratory resuscitation. 
The clinical significance of this finding depends on whether 
the therapeutic and toxic effects of the administered drug 
are related to peak blood levels or to the subsequent steady 
lACC Vol. 6, No.5 
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state or plateau levels (Fig, 3), If the peak level is critical 
for therapeutic effect, central administration would be pref•
erable because higher levels can be achieved more efficiently 
by this route, In contrast, if the plateau level is important, 
little difference in outcome is likely to result from the two 
routes of administration, In fact, if the peak concentration 
is responsible for toxicity but has no therapeutic benefit, 
peripheral injection may be advantageous, Because the op•
timal approach will differ among drugs, a general recom•
mendation cannot be made, However, it is important to 
recognize that the outcome of resuscitation efforts may be 
affected adversely if a significant period of highly toxic drug 
levels occurs after central venous administration during car•
diopulmonary resuscitation, Further investigation is needed 
to compare the pharmacokinetics of central venous and pe•
ripheral venous routes with various drugs used during car•
diorespiratory resuscitation, 
We thank Barry Massie, MD for his helpful comments. 
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